nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—NOS2—Doxorubicin—thyroid cancer	0.375	0.5	CbGbCtD
L-Arginine—NOS3—Doxorubicin—thyroid cancer	0.375	0.5	CbGbCtD
L-Arginine—SLC22A4—larynx—thyroid cancer	0.0111	0.0964	CbGeAlD
L-Arginine—Brain oedema—Vandetanib—thyroid cancer	0.00817	0.209	CcSEcCtD
L-Arginine—ARG2—neck—thyroid cancer	0.00658	0.0573	CbGeAlD
L-Arginine—AZIN2—thyroid gland—thyroid cancer	0.00601	0.0523	CbGeAlD
L-Arginine—ASL—thyroid gland—thyroid cancer	0.00559	0.0487	CbGeAlD
L-Arginine—SLC7A4—head—thyroid cancer	0.00556	0.0484	CbGeAlD
L-Arginine—ARG2—saliva-secreting gland—thyroid cancer	0.00513	0.0447	CbGeAlD
L-Arginine—ASL—head—thyroid cancer	0.00496	0.0432	CbGeAlD
L-Arginine—NOS3—neck—thyroid cancer	0.0046	0.04	CbGeAlD
L-Arginine—ARG2—trachea—thyroid cancer	0.00396	0.0345	CbGeAlD
L-Arginine—Platelet count decreased—Vandetanib—thyroid cancer	0.00393	0.101	CcSEcCtD
L-Arginine—AZIN2—lymph node—thyroid cancer	0.00373	0.0325	CbGeAlD
L-Arginine—SLC7A1—thyroid gland—thyroid cancer	0.00366	0.0319	CbGeAlD
L-Arginine—ASS1—saliva-secreting gland—thyroid cancer	0.0036	0.0313	CbGeAlD
L-Arginine—ASL—lymph node—thyroid cancer	0.00347	0.0302	CbGeAlD
L-Arginine—SLC16A10—neck—thyroid cancer	0.00329	0.0287	CbGeAlD
L-Arginine—SLC7A1—head—thyroid cancer	0.00325	0.0283	CbGeAlD
L-Arginine—ARG2—thyroid gland—thyroid cancer	0.00313	0.0273	CbGeAlD
L-Arginine—SLC22A4—neck—thyroid cancer	0.00293	0.0256	CbGeAlD
L-Arginine—ARG2—head—thyroid cancer	0.00278	0.0242	CbGeAlD
L-Arginine—ASS1—trachea—thyroid cancer	0.00278	0.0242	CbGeAlD
L-Arginine—NOS3—trachea—thyroid cancer	0.00277	0.0241	CbGeAlD
L-Arginine—SLC7A1—lymph node—thyroid cancer	0.00227	0.0198	CbGeAlD
L-Arginine—ASS1—thyroid gland—thyroid cancer	0.0022	0.0191	CbGeAlD
L-Arginine—NOS3—thyroid gland—thyroid cancer	0.00219	0.0191	CbGeAlD
L-Arginine—ASS1—head—thyroid cancer	0.00195	0.017	CbGeAlD
L-Arginine—ARG2—lymph node—thyroid cancer	0.00195	0.0169	CbGeAlD
L-Arginine—NOS3—head—thyroid cancer	0.00194	0.0169	CbGeAlD
L-Arginine—SLC22A4—trachea—thyroid cancer	0.00177	0.0154	CbGeAlD
L-Arginine—Lethargy—Vandetanib—thyroid cancer	0.00173	0.0443	CcSEcCtD
L-Arginine—Skin necrosis—Epirubicin—thyroid cancer	0.00167	0.0427	CcSEcCtD
L-Arginine—SLC16A10—thyroid gland—thyroid cancer	0.00157	0.0137	CbGeAlD
L-Arginine—Skin necrosis—Doxorubicin—thyroid cancer	0.00154	0.0395	CcSEcCtD
L-Arginine—SLC22A5—saliva-secreting gland—thyroid cancer	0.00151	0.0132	CbGeAlD
L-Arginine—Skin exfoliation—Sorafenib—thyroid cancer	0.0015	0.0385	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.00143	0.0149	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—LGALS3—thyroid cancer	0.00142	0.0148	CbGpPWpGaD
L-Arginine—SLC22A4—thyroid gland—thyroid cancer	0.0014	0.0122	CbGeAlD
L-Arginine—ASS1—lymph node—thyroid cancer	0.00136	0.0119	CbGeAlD
L-Arginine—NOS3—lymph node—thyroid cancer	0.00136	0.0118	CbGeAlD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—NDUFA13—thyroid cancer	0.00125	0.013	CbGpPWpGaD
L-Arginine—Haematuria—Vandetanib—thyroid cancer	0.00125	0.0319	CcSEcCtD
L-Arginine—ARG2—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.00119	0.0124	CbGpPWpGaD
L-Arginine—SLC22A5—trachea—thyroid cancer	0.00117	0.0102	CbGeAlD
L-Arginine—NOS3—Angiogenesis—HIF1A—thyroid cancer	0.00117	0.0121	CbGpPWpGaD
L-Arginine—SLC16A10—Amino acid and oligopeptide SLC transporters—SLC5A5—thyroid cancer	0.00117	0.0121	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.00112	0.0117	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—LGALS3—thyroid cancer	0.0011	0.0115	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—MINPP1—thyroid cancer	0.00104	0.0109	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—HIF1A—thyroid cancer	0.001	0.0104	CbGpPWpGaD
L-Arginine—SLC16A10—lymph node—thyroid cancer	0.000974	0.00848	CbGeAlD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000958	0.00996	CbGpPWpGaD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000958	0.00996	CbGpPWpGaD
L-Arginine—ASL—Metabolism—MINPP1—thyroid cancer	0.000956	0.00994	CbGpPWpGaD
L-Arginine—SLC22A5—thyroid gland—thyroid cancer	0.000924	0.00805	CbGeAlD
L-Arginine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000917	0.00954	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000912	0.00949	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—LGALS3—thyroid cancer	0.000893	0.00929	CbGpPWpGaD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00089	0.00926	CbGpPWpGaD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00089	0.00926	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—NDUFA13—thyroid cancer	0.000888	0.00924	CbGpPWpGaD
L-Arginine—SLC22A4—lymph node—thyroid cancer	0.000868	0.00756	CbGeAlD
L-Arginine—NOS3—eNOS activation—AKT1—thyroid cancer	0.00086	0.00894	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CHST14—thyroid cancer	0.000835	0.00869	CbGpPWpGaD
L-Arginine—ASS1—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.000828	0.00861	CbGpPWpGaD
L-Arginine—ASL—Metabolism—NDUFA13—thyroid cancer	0.000813	0.00845	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—MINPP1—thyroid cancer	0.000792	0.00824	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CHST14—thyroid cancer	0.000764	0.00795	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—PTGS2—thyroid cancer	0.000744	0.00773	CbGpPWpGaD
L-Arginine—Necrosis—Epirubicin—thyroid cancer	0.000742	0.019	CcSEcCtD
L-Arginine—Flushing—Sorafenib—thyroid cancer	0.000734	0.0188	CcSEcCtD
L-Arginine—Decreased appetite—Vandetanib—thyroid cancer	0.000725	0.0185	CcSEcCtD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000717	0.00746	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.0007	0.00728	CbGpPWpGaD
L-Arginine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000689	0.00717	CbGpPWpGaD
L-Arginine—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.000687	0.00714	CbGpPWpGaD
L-Arginine—Necrosis—Doxorubicin—thyroid cancer	0.000687	0.0176	CcSEcCtD
L-Arginine—NOS3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—thyroid cancer	0.000683	0.00711	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—NDUFA13—thyroid cancer	0.000673	0.007	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—HPGD—thyroid cancer	0.000673	0.007	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—HIF1A—thyroid cancer	0.000669	0.00696	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000669	0.00696	CbGpPWpGaD
L-Arginine—Extravasation—Epirubicin—thyroid cancer	0.000668	0.0171	CcSEcCtD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000666	0.00693	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CHST14—thyroid cancer	0.000633	0.00658	CbGpPWpGaD
L-Arginine—Extravasation—Doxorubicin—thyroid cancer	0.000618	0.0158	CcSEcCtD
L-Arginine—ASL—Metabolism—HPGD—thyroid cancer	0.000616	0.0064	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CDK1—thyroid cancer	0.00061	0.00634	CbGpPWpGaD
L-Arginine—Injection site reaction—Epirubicin—thyroid cancer	0.000579	0.0148	CcSEcCtD
L-Arginine—SLC22A5—lymph node—thyroid cancer	0.000574	0.005	CbGeAlD
L-Arginine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000562	0.0144	CcSEcCtD
L-Arginine—Skin exfoliation—Epirubicin—thyroid cancer	0.000556	0.0142	CcSEcCtD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—PRKAR1A—thyroid cancer	0.000553	0.00575	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—MINPP1—thyroid cancer	0.000549	0.00571	CbGpPWpGaD
L-Arginine—Anorexia—Sorafenib—thyroid cancer	0.000536	0.0137	CcSEcCtD
L-Arginine—Injection site reaction—Doxorubicin—thyroid cancer	0.000536	0.0137	CcSEcCtD
L-Arginine—Vomiting—Vandetanib—thyroid cancer	0.00053	0.0136	CcSEcCtD
L-Arginine—Rash—Vandetanib—thyroid cancer	0.000526	0.0135	CcSEcCtD
L-Arginine—Dermatitis—Vandetanib—thyroid cancer	0.000525	0.0134	CcSEcCtD
L-Arginine—Headache—Vandetanib—thyroid cancer	0.000522	0.0134	CcSEcCtD
L-Arginine—NOS3—AGE/RAGE pathway—HIF1A—thyroid cancer	0.00052	0.0054	CbGpPWpGaD
L-Arginine—Skin exfoliation—Doxorubicin—thyroid cancer	0.000514	0.0132	CcSEcCtD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—CDK1—thyroid cancer	0.000512	0.00533	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—HPGD—thyroid cancer	0.00051	0.00531	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—thyroid cancer	0.000499	0.00519	CbGpPWpGaD
L-Arginine—Nausea—Vandetanib—thyroid cancer	0.000495	0.0127	CcSEcCtD
L-Arginine—Decreased appetite—Sorafenib—thyroid cancer	0.000489	0.0125	CcSEcCtD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000487	0.00506	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000487	0.00506	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—CDK1—thyroid cancer	0.000483	0.00503	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000479	0.00498	CbGpPWpGaD
L-Arginine—NOS3—Metabolism of nitric oxide—AKT1—thyroid cancer	0.000473	0.00492	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NDUFA13—thyroid cancer	0.000467	0.00485	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000452	0.00471	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000452	0.00471	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000445	0.00463	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000443	0.0046	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CCND1—thyroid cancer	0.000442	0.0046	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CHST14—thyroid cancer	0.000439	0.00456	CbGpPWpGaD
L-Arginine—Lethargy—Epirubicin—thyroid cancer	0.000431	0.011	CcSEcCtD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—CALCA—thyroid cancer	0.000421	0.00438	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—thyroid cancer	0.00042	0.00437	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000417	0.00434	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000417	0.00434	CbGpPWpGaD
L-Arginine—Hypersensitivity—Sorafenib—thyroid cancer	0.000414	0.0106	CcSEcCtD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00041	0.00427	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00041	0.00427	CbGpPWpGaD
L-Arginine—Lethargy—Doxorubicin—thyroid cancer	0.000399	0.0102	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.000396	0.00412	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—AKT1—thyroid cancer	0.000392	0.00408	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—TPR—thyroid cancer	0.000387	0.00402	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PRKAR1A—thyroid cancer	0.00038	0.00396	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000364	0.00379	CbGpPWpGaD
L-Arginine—Vomiting—Sorafenib—thyroid cancer	0.000357	0.00915	CcSEcCtD
L-Arginine—Rash—Sorafenib—thyroid cancer	0.000355	0.00908	CcSEcCtD
L-Arginine—Dermatitis—Sorafenib—thyroid cancer	0.000354	0.00907	CcSEcCtD
L-Arginine—ASL—Metabolism—TPR—thyroid cancer	0.000354	0.00368	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—HPGD—thyroid cancer	0.000354	0.00368	CbGpPWpGaD
L-Arginine—Headache—Sorafenib—thyroid cancer	0.000352	0.00902	CcSEcCtD
L-Arginine—ASL—Metabolism—PRKAR1A—thyroid cancer	0.000348	0.00362	CbGpPWpGaD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—AKT1—thyroid cancer	0.000347	0.00361	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—thyroid cancer	0.000344	0.00358	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.000341	0.00354	CbGpPWpGaD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000339	0.00352	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—AKT1—thyroid cancer	0.000337	0.00351	CbGpPWpGaD
L-Arginine—Nausea—Sorafenib—thyroid cancer	0.000334	0.00855	CcSEcCtD
L-Arginine—NOS3—Corticotropin-releasing hormone—BRAF—thyroid cancer	0.00033	0.00343	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000313	0.00326	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000313	0.00326	CbGpPWpGaD
L-Arginine—NOS2—Disease—TRIM24—thyroid cancer	0.000312	0.00325	CbGpPWpGaD
L-Arginine—Sweating—Epirubicin—thyroid cancer	0.000312	0.008	CcSEcCtD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000312	0.00325	CbGpPWpGaD
L-Arginine—Haematuria—Epirubicin—thyroid cancer	0.000311	0.00795	CcSEcCtD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000307	0.00319	CbGpPWpGaD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000306	0.00318	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—NRAS—thyroid cancer	0.0003	0.00312	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—thyroid cancer	0.000296	0.00308	CbGpPWpGaD
L-Arginine—NOS2—Disease—CHST14—thyroid cancer	0.000294	0.00305	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—TPR—thyroid cancer	0.000293	0.00305	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000291	0.00745	CcSEcCtD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.00029	0.00301	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—SLC5A5—thyroid cancer	0.000289	0.00301	CbGpPWpGaD
L-Arginine—Sweating—Doxorubicin—thyroid cancer	0.000289	0.0074	CcSEcCtD
L-Arginine—ARG2—Metabolism—PRKAR1A—thyroid cancer	0.000288	0.003	CbGpPWpGaD
L-Arginine—Haematuria—Doxorubicin—thyroid cancer	0.000287	0.00736	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000285	0.00296	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—CCND1—thyroid cancer	0.000284	0.00295	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—PTGS2—thyroid cancer	0.000281	0.00292	CbGpPWpGaD
L-Arginine—NOS2—Disease—TRIM33—thyroid cancer	0.000278	0.0029	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PRKAR1A—thyroid cancer	0.000276	0.00287	CbGpPWpGaD
L-Arginine—Flushing—Epirubicin—thyroid cancer	0.000271	0.00695	CcSEcCtD
L-Arginine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000269	0.00689	CcSEcCtD
L-Arginine—ASL—Metabolism—SLC5A5—thyroid cancer	0.000265	0.00275	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—thyroid cancer	0.000263	0.00274	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—KRAS—thyroid cancer	0.000258	0.00268	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.000256	0.00266	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CCND1—thyroid cancer	0.000254	0.00264	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—thyroid cancer	0.000252	0.00262	CbGpPWpGaD
L-Arginine—Flushing—Doxorubicin—thyroid cancer	0.000251	0.00643	CcSEcCtD
L-Arginine—AZIN2—Metabolism—RXRA—thyroid cancer	0.000243	0.00253	CbGpPWpGaD
L-Arginine—NOS3—Disease—TRIM24—thyroid cancer	0.000243	0.00252	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—MINPP1—thyroid cancer	0.000239	0.00248	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000235	0.00244	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—PPARG—thyroid cancer	0.000233	0.00243	CbGpPWpGaD
L-Arginine—NOS3—Disease—CHST14—thyroid cancer	0.000228	0.00237	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000225	0.00234	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—AKT1—thyroid cancer	0.000225	0.00234	CbGpPWpGaD
L-Arginine—ASL—Metabolism—RXRA—thyroid cancer	0.000222	0.00231	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thyroid cancer	0.000222	0.00231	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—SLC5A5—thyroid cancer	0.000219	0.00228	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—HRAS—thyroid cancer	0.000219	0.00228	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—AKT1—thyroid cancer	0.000218	0.00227	CbGpPWpGaD
L-Arginine—NOS3—Disease—TRIM33—thyroid cancer	0.000216	0.00225	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PRKAR1A—thyroid cancer	0.000215	0.00223	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000212	0.0022	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—CP—thyroid cancer	0.000212	0.0022	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—BRAF—thyroid cancer	0.00021	0.00218	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—CP—thyroid cancer	0.000208	0.00217	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000208	0.00217	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000208	0.00217	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000208	0.00532	CcSEcCtD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000205	0.00213	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TPR—thyroid cancer	0.000203	0.00211	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NDUFA13—thyroid cancer	0.000203	0.00211	CbGpPWpGaD
L-Arginine—Tachycardia—Epirubicin—thyroid cancer	0.000203	0.00519	CcSEcCtD
L-Arginine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000201	0.00514	CcSEcCtD
L-Arginine—ASS1—Metabolism—PRKAR1A—thyroid cancer	0.0002	0.00208	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—AKT1—thyroid cancer	0.000199	0.00207	CbGpPWpGaD
L-Arginine—Anorexia—Epirubicin—thyroid cancer	0.000198	0.00507	CcSEcCtD
L-Arginine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000192	0.00492	CcSEcCtD
L-Arginine—NOS3—Metabolism—CHST14—thyroid cancer	0.000191	0.00199	CbGpPWpGaD
L-Arginine—Tachycardia—Doxorubicin—thyroid cancer	0.000188	0.0048	CcSEcCtD
L-Arginine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000186	0.00476	CcSEcCtD
L-Arginine—NOS2—Disease—TCF7L1—thyroid cancer	0.000186	0.00193	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—RXRA—thyroid cancer	0.000184	0.00192	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—NRAS—thyroid cancer	0.000184	0.00191	CbGpPWpGaD
L-Arginine—Anorexia—Doxorubicin—thyroid cancer	0.000183	0.00469	CcSEcCtD
L-Arginine—NOS2—Hemostasis—IFNA2—thyroid cancer	0.000183	0.0019	CbGpPWpGaD
L-Arginine—Decreased appetite—Epirubicin—thyroid cancer	0.000181	0.00462	CcSEcCtD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—thyroid cancer	0.000179	0.00186	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—AKT1—thyroid cancer	0.000175	0.00182	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—NRAS—thyroid cancer	0.000173	0.0018	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thyroid cancer	0.000171	0.00177	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—thyroid cancer	0.000167	0.00174	CbGpPWpGaD
L-Arginine—Decreased appetite—Doxorubicin—thyroid cancer	0.000167	0.00428	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—PTEN—thyroid cancer	0.00016	0.00167	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CALCB—thyroid cancer	0.00016	0.00166	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000159	0.00166	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—CP—thyroid cancer	0.000159	0.00166	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000159	0.00165	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KRAS—thyroid cancer	0.000158	0.00164	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—AKT1—thyroid cancer	0.000158	0.00164	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000157	0.00163	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000156	0.00162	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HPGD—thyroid cancer	0.000154	0.0016	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PPARG—thyroid cancer	0.000154	0.0016	CbGpPWpGaD
L-Arginine—Hypersensitivity—Epirubicin—thyroid cancer	0.000153	0.00392	CcSEcCtD
L-Arginine—ASS1—Metabolism—SLC5A5—thyroid cancer	0.000152	0.00158	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TRIM33—thyroid cancer	0.000151	0.00157	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—KRAS—thyroid cancer	0.000149	0.00155	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—PTEN—thyroid cancer	0.000148	0.00154	CbGpPWpGaD
L-Arginine—NOS3—Disease—TCF7L1—thyroid cancer	0.000144	0.0015	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IFNA2—thyroid cancer	0.000142	0.00148	CbGpPWpGaD
L-Arginine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000142	0.00363	CcSEcCtD
L-Arginine—ASL—Metabolism—PPARG—thyroid cancer	0.00014	0.00146	CbGpPWpGaD
L-Arginine—NOS2—Disease—TPR—thyroid cancer	0.000136	0.00141	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—thyroid cancer	0.000134	0.0014	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.000134	0.00139	CbGpPWpGaD
L-Arginine—NOS2—Disease—PRKAR1A—thyroid cancer	0.000134	0.00139	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000133	0.00139	CbGpPWpGaD
L-Arginine—Vomiting—Epirubicin—thyroid cancer	0.000132	0.00338	CcSEcCtD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000131	0.00136	CbGpPWpGaD
L-Arginine—Rash—Epirubicin—thyroid cancer	0.000131	0.00335	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—thyroid cancer	0.000131	0.00335	CcSEcCtD
L-Arginine—Headache—Epirubicin—thyroid cancer	0.00013	0.00333	CcSEcCtD
L-Arginine—NOS2—Disease—MEN1—thyroid cancer	0.000128	0.00133	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—RXRA—thyroid cancer	0.000128	0.00133	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—thyroid cancer	0.000127	0.00132	CbGpPWpGaD
L-Arginine—Nausea—Epirubicin—thyroid cancer	0.000123	0.00316	CcSEcCtD
L-Arginine—Vomiting—Doxorubicin—thyroid cancer	0.000122	0.00313	CcSEcCtD
L-Arginine—Rash—Doxorubicin—thyroid cancer	0.000121	0.0031	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—thyroid cancer	0.000121	0.0031	CcSEcCtD
L-Arginine—AZIN2—Metabolism—PTGS2—thyroid cancer	0.000121	0.00126	CbGpPWpGaD
L-Arginine—Headache—Doxorubicin—thyroid cancer	0.00012	0.00308	CcSEcCtD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000119	0.00124	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—AKT1—thyroid cancer	0.000119	0.00123	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PPARG—thyroid cancer	0.000116	0.00121	CbGpPWpGaD
L-Arginine—Nausea—Doxorubicin—thyroid cancer	0.000114	0.00292	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—KRAS—thyroid cancer	0.000113	0.00118	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—AKT1—thyroid cancer	0.000112	0.00117	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—thyroid cancer	0.00011	0.00115	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—thyroid cancer	0.000109	0.00114	CbGpPWpGaD
L-Arginine—NOS3—Disease—TPR—thyroid cancer	0.000106	0.0011	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTEN—thyroid cancer	0.000105	0.0011	CbGpPWpGaD
L-Arginine—NOS3—Disease—PRKAR1A—thyroid cancer	0.000104	0.00108	CbGpPWpGaD
L-Arginine—NOS2—Disease—CALCA—thyroid cancer	0.000102	0.00106	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TCF7L1—thyroid cancer	0.000101	0.00105	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.0001	0.00104	CbGpPWpGaD
L-Arginine—NOS3—Disease—MEN1—thyroid cancer	9.93e-05	0.00103	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	9.65e-05	0.001	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTEN—thyroid cancer	9.64e-05	0.001	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDK1—thyroid cancer	9.21e-05	0.000958	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—thyroid cancer	9.16e-05	0.000952	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TPR—thyroid cancer	8.84e-05	0.00092	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PRKAR1A—thyroid cancer	8.7e-05	0.000905	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	8.52e-05	0.000886	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PPARG—thyroid cancer	8.07e-05	0.000839	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTEN—thyroid cancer	7.98e-05	0.00083	CbGpPWpGaD
L-Arginine—NOS3—Disease—CALCA—thyroid cancer	7.9e-05	0.000822	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRG1—thyroid cancer	7.4e-05	0.000769	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TSHR—thyroid cancer	7.39e-05	0.000769	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKAR1A—thyroid cancer	7.27e-05	0.000757	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDK1—thyroid cancer	7.15e-05	0.000744	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MEN1—thyroid cancer	6.95e-05	0.000723	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—thyroid cancer	6.83e-05	0.00071	CbGpPWpGaD
L-Arginine—NOS2—Disease—TERT—thyroid cancer	6.64e-05	0.000691	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC5A5—thyroid cancer	6.62e-05	0.000688	CbGpPWpGaD
L-Arginine—NOS2—Disease—HIF1A—thyroid cancer	6.35e-05	0.000661	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—thyroid cancer	6.35e-05	0.00066	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTCH1—thyroid cancer	6.29e-05	0.000654	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—thyroid cancer	6.07e-05	0.000632	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—thyroid cancer	5.88e-05	0.000611	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SST—thyroid cancer	5.75e-05	0.000598	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRG1—thyroid cancer	5.74e-05	0.000597	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—RXRA—thyroid cancer	5.56e-05	0.000578	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—thyroid cancer	5.55e-05	0.000578	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CALCA—thyroid cancer	5.53e-05	0.000576	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—thyroid cancer	5.53e-05	0.000576	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—thyroid cancer	5.3e-05	0.000551	CbGpPWpGaD
L-Arginine—NOS2—Disease—BRAF—thyroid cancer	5.26e-05	0.000547	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—thyroid cancer	5.22e-05	0.000543	CbGpPWpGaD
L-Arginine—NOS3—Disease—TERT—thyroid cancer	5.16e-05	0.000536	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDK1—thyroid cancer	5.01e-05	0.000521	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—thyroid cancer	4.99e-05	0.000519	CbGpPWpGaD
L-Arginine—NOS3—Disease—HIF1A—thyroid cancer	4.93e-05	0.000513	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—thyroid cancer	4.6e-05	0.000479	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—thyroid cancer	4.56e-05	0.000475	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—thyroid cancer	4.41e-05	0.000459	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—thyroid cancer	4.25e-05	0.000442	CbGpPWpGaD
L-Arginine—NOS3—Disease—BRAF—thyroid cancer	4.08e-05	0.000425	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—thyroid cancer	4.05e-05	0.000422	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRG1—thyroid cancer	4.02e-05	0.000418	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—thyroid cancer	3.88e-05	0.000403	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—thyroid cancer	3.7e-05	0.000385	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TERT—thyroid cancer	3.61e-05	0.000376	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPARG—thyroid cancer	3.51e-05	0.000365	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HIF1A—thyroid cancer	3.45e-05	0.000359	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—thyroid cancer	3.42e-05	0.000356	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—thyroid cancer	3.31e-05	0.000344	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—thyroid cancer	3.3e-05	0.000343	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—thyroid cancer	3.19e-05	0.000332	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—thyroid cancer	2.88e-05	0.000299	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BRAF—thyroid cancer	2.86e-05	0.000297	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—thyroid cancer	2.84e-05	0.000296	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—thyroid cancer	2.76e-05	0.000287	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—thyroid cancer	2.57e-05	0.000267	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—thyroid cancer	2.42e-05	0.000251	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—thyroid cancer	2.41e-05	0.000251	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—thyroid cancer	2.21e-05	0.00023	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—thyroid cancer	2.13e-05	0.000222	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—thyroid cancer	2.09e-05	0.000217	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—thyroid cancer	2.01e-05	0.00021	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—thyroid cancer	1.88e-05	0.000195	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—thyroid cancer	1.8e-05	0.000187	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—thyroid cancer	1.66e-05	0.000172	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—thyroid cancer	1.55e-05	0.000161	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—thyroid cancer	1.39e-05	0.000144	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—thyroid cancer	1.37e-05	0.000143	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—thyroid cancer	1.31e-05	0.000137	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—thyroid cancer	1.16e-05	0.000121	CbGpPWpGaD
